OMGA
Omega Therapeutics, Inc.
No insider bought or sold Omega Therapeutics, Inc. in the last 12 months
$0Bought, 12 mo
$0Sold, 12 mo
OMGA over the last year
Prices for OMGA aren't in yet.
OMGA after insider buys
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Every filing
11 insider filings since 2021, newest first
OMGASell
Richard A Young · Director
$40K−1.0%Jun 5
OMGASell
Richard A Young · Director
$40K−1.0%May 3
OMGASell
Richard A Young · Director
$40K−1.0%Apr 10
OMGASell
Richard A Young · Director
$80K−1.0%Mar 20
OMGABuy
Flagship Pioneering Inc. · 10% owner
$19.2M+13.0%Feb 27
OMGASell
Richard A Young · Director
$160K−3.0%Jan 11
OMGASell
Richard A Young · Director
$80K−1.0%Sep 15
OMGABuy
Flagship Pioneering Inc. · 10% owner
$20.0M+45.0%Aug 5
OMGABuy
Roger Sawhney · CFO
$50KAug 3
OMGABuy
Invus Public Equities, L.P. · 10% owner
$16.1M+72.0%Aug 3
OMGABuy
David A Berry · Director
$902KAug 3
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.